ONE-SAMPLE MULTIPLE TESTING PROCEDURE FOR PHASE II CLINICAL TRIALSFLEMING TR.1982; BIOMETRICS; ISSN 0006-341X; USA; DA. 1982; VOL. 38; NO 1; PP. 143-151; ABS. FRE; BIBL. 11 REF.Article

CLINICAL STUDIES. V: RATIONALE, DESIGN, AND METHODOLOGY OF PHASE II CLINICAL TRIALSMUGOIA FM; MCGUIRE WP; PROZENCWEIG M et al.1979; METHODS CANCER RES.; USA; DA. 1979; VOL. 17; PP. 199-214; BIBL. 2 P.Article

THE MEASUREMENT OF THERAPEUTIC VALUEWARDELL WM; DIRADDO J; WEINTRAUB M et al.1980; J. CLIN. PHARMACOL.; USA; DA. 1980; VOL. 20; NO 2-3; PP. 77-90; BIBL. 32 REF.Article

PHASE II STUDY OF ANTINEOPLASTIC AGENTS IN JAPANMAJIMA H.1980; RECENT RESULTS CANCER RES.; DEU; DA. 1980; VOL. 70; PP. 61-65; BIBL. 7 REF.Conference Paper

PHASE II TRIAL OF AZIRIDINYLBENZOQUINONE (AZQ) IN PATIENTS WITH REFRACTORY LYMPHOMA = ESSAI PHASE II DE L'AZIRIDINYLBENZOQUINONE (AZQ) DANS LES LYMPHOMES REFRACTAIRESMCLAUGHLIN P; CABANILLAS F; BEDIKIAN AY et al.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 5; PP. 507-508; BIBL. 5 REF.; GRAPHArticle

PHASE II TRIAL OF PREDNIMUSTINE IN CHILDREN WITH RECURRENT CANCER: A CHILDREN'S CANCER STUDY GROUP REPORTGAYNON PS; BAUM ES; KRIVIT W et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 7; PP. 1583-1584; BIBL. 5 REF.Article

PHASE II TRIALS OF METHYLGLYOXAL-BIS (GUANYLHYDRAZONE)KELSEN DP; YAGODA A; WARRELL R et al.1982; AM. J. CLIN. ONCOL.; ISSN 512273; USA; DA. 1982; VOL. 5; NO 2; PP. 221-225; BIBL. 16 REF.Article

PHASE II STUDY OF DIBROMODULCITOL IN COLORECTAL, KIDNEY, AND OTHER CARCINOMASMISCHLER NE; TORMEY DC; KLOTZ J et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 4; PP. 407-410; BIBL. 11 REF.Article

THE CLINICAL EVALUATION OF ANALOGUES. IV: NITROSOUREASCARTER SK.1980; RECENT RESULTS CANCER RES.; DEU; DA. 1980; VOL. 70; PP. 119-123; BIBL. 6 REF.Conference Paper

CHIMIOTHERAPIE DES CANCERS PAR LE CIS-DIAMMINO-DICHLOROPLATINUM ESSAI THERAPEUTIQUE PHASE IIHAYAT M; BAYSSAS M; BRULE G et al.1979; NOUV. PRESSE MED.; FRA; DA. 1979; VOL. 8; NO 15; PP. 1231-1234; ABS. ENG; BIBL. 25 REF.Article

PROBLEMS IN TESTING HYPOLIPIDEMIC AGENTS IN PHASE IISCHWANDT P.1980; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1980; VOL. 18; NO 8; PP. 370-373; BIBL. 8 REF.Article

TIME-BLIND ANALYSIS AND OTHER VIDEO-STRATEGIES IN PHASE II TRIALS OF PSYCHOTROPIC DRUGSMULLER OERLINGHAUSEN B; RENFORDT E.1980; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1980; VOL. 18; NO 3; PP. 99-103; BIBL. 22 REF.Article

PHASE II STUDY OF VP-16-213 IN CHILDHOOD MALIGNANT DISEASE: A CHILDREN'S CANCER STUDY GROUP REPORTCHARD RL JR; KRIVIT W; BLEYER WA et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 1755-1759; BIBL. 12 REF.Article

TWO-STAGE PLANS FOR PATIENT ACCRUAL IN PHASE II CANCER CLINICAL TRIALSLEE YJ; STAQUET M; SIMON R et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 1721-1726; BIBL. 8 REF.Article

A PHASE II CLINICAL TRIAL OF PEPTICHEMIO. CLINICAL SCREENING COOPERATIVE GROUP OF EUROPEAN ORGANISATION ON RESEARCH ON TREATMENT OF CANCER (E.O.R.T.C.).1977; BIOMEDICINE; FR.; DA. 1977; VOL. 27; NO 8; PP. 290-294; ABS. FR.; BIBL. 15 REF.Article

PHASE II EVALUATION OF CYCLOLEUCINE IN THE TREATMENT OF PATIENTS WITH DISSEMINATED SARCOMASBAKER LH; FRAILE RJ; SAMSON MK et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 3-4; PP. 358-359; BIBL. 3 REF.Article

RADIATION THERAPY ONCOLOGY GROUP CLINICAL TRIALS WITH MISONIDAZOLEWASSERMAN TH; STETZ J; PHILLIPS TL et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 10; PP. 2382-2390; BIBL. 16 REF.Article

BIOLOGIC RESPONSE-MODIFYING AGENTS: WHAT IS AN APPROPRIATE PHASE I-II STRATEGY.CARTER SK.1980; CANCER IMMUNOL. IMMUNOTHER.; ISSN 0340-7004; DEU; DA. 1980; VOL. 8; NO 4; PP. 207-210; BIBL. 4 REF.Article

METHODOLOGY OF PHASE II CLINICAL TRIAL IN CANCERMUGGIA FM; ROZENCWEIG M; STAQUET MJ et al.1980; RECENT RESULTS CANCER RES.; DEU; DA. 1980; VOL. 70; PP. 53-60; BIBL. 17 REF.Conference Paper

PRELIMINARY RESULTS OF A PHASE II TRIAL ON SOLID TUMORS OF DETORUBICIN, A NEW ANTHRACYCLIN1980; CANCER CLIN. TRIALS; USA; DA. 1980; VOL. 3; NO 2; PP. 115-120; BIBL. 14 REF.Article

PHASE II TRIAL OF VINDESINE IN PATIENTS WITH MALIGNANT LYMPHOMASKLAROFF RB; STRAUSS D; YOUNG C et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 793-794; BIBL. 11 REF.Article

PRACTICAL SIDE OF MULTISTAGE CLINICAL TRIALS FOR SCREENING NEW AGENTS = COTE PRATIQUE DES ESSAIS CLINIQUES EN PLUSIEURS ETAPES POUR LA RECHERCHE DE NOUVEAUX AGENTS ANTITUMORAUXHERSON J.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 1; PP. 71-75; ABS. ENG; BIBL. 15 REF.; GRAPHArticle

A PHASE II TRIAL OF M-AMSA IN HEAD AND NECK CANCERFORASTIERE AA; YOUNG CW; WITTES RE et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 6; NO 2; PP. 145-146; BIBL. 8 REF.Article

NEW SIDE EFFECT OF THE HYPOXIC CELL SENSITIZER, MISONIDAZOLEPARTINGTON J; KOZIOL D; CHAPMAN D et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 1; PP. 123-125; BIBL. 9 REF.Article

A DECISION THEORY APPROACH TO PHASE II CLINICAL TRIALS.STAQUET M; SYLVESTER R.1977; BIOMEDICINE; FR.; DA. 1977; VOL. 26; NO 4; PP. 262-266; BIBL. 8 REF.Article